Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
FGS/MGS/STI
Study of Reproductive Health in Rural Madagascar With Emphasis on Urogenital Schistosomiasis and Sexually Transmitted Infections
FGS/MGS/STI
Study of Reproductive Health in Rural Madagascar With Emphasis on Urogenital Schistosomiasis and Sexually Transmitted Infections
Sponsor study identifier
Secondary identifiers
interventional
680
1 country
1
Study Start
August 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2002
Actual (reported)Study Completion
September 2003
Actual (reported)A cross-sectional study of urogenital schistosomiasis and sexually transmitted infections (STI) prevalence and associated morbidity in a rural community in Madagascar. Clearance of infections and resolution of morbidity were subsequently studied in two phases following systematic anti-STI and anti-schistosoma treatment, respectively.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2003
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 2001
Date type not reportedThis date has not been verified as actual or estimated.
April 2002
Actual (reported)September 2003
Actual (reported)July 8, 2008
Actual (reported)July 14, 2008
Actual (reported)Measurement of urogenital schistosomiasis and STI prevalence
2 months
Urogenital and STI associated morbidity
2 months
Baseline and post-treatment follow-up (anti-STI and praziquantel Rx)
Anti-STI regimen: ciprofloxacin 500mg orally, doxycycline 100mg BID orally 7 days and metronidazole 2g orally (cefuroxime im and/or azithromycin alternatively for pregnant and breastfeeding women) Anti-schistosoma regimen: Praziquantel 40mg/kg
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Institut Pasteur
Antananarivo, 100, Madagascar
Peter DC Leutscher, MD, PhD
Danish Bilharziasis Laboratory
680 participants (actual enrollment reported by the registry).
First Submitted
July 8, 2008
First Posted
July 14, 2008
Study Start
August 2001
Date type not reportedThis date has not been verified as actual or estimated.
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Contact the study team to confirm eligibility.
Primary Completion
April 2002
Actual (reported)Study Completion
September 2003
Actual (reported)Last Updated
July 14, 2008
Record last verified: 2008-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: